Adjusted for time since infection, mucosal spike IgA levels were 1.26-fold [95% CI 1.03–1.54] higher in participants infected prior to vaccination (G1-2 in Fig. 2) as compared to in those in whom the breakthrough infection was the first viral encounter (G4 in Fig. 2) (M4, Fig. 6). Here, CD79A is linked to infection.